AELIX Therapeutics and Gilead Sciences Enter into a Clinical Research Collaboration Agreement to Evaluate a ...
(WorldNews Business)

BARCELONA, Spain--(BUSINESS WIRE)--Oct 18, 2018--AELIX Therapeutics S.L. (`AELIX`), a clinical-stage biotechnology company specialized in the discovery and development of immunotherapies for HIV infection, today announces that it has entered into a clinical research collaboration with Gilead Sciences, Inc. (`Gilead`), a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need, to jointly evaluate proprietary investigational products in a strategic clinical study aimed at achieving a functional cure of HIV infection. The collaboration will enable the conduct of a clinical study, entitled AELIX-003, to investigate...